Wei, J, Schottenfeld, D, Cooper, K, Taylor, JMG, Faerber, G, Velarde, M, Bree, R,
Montie, J, Cooney, K: “The Natural History of Lower Urinary Tract Symptoms Among African-American
Men: Relationships with Aging, Prostate Size, Flow Rate and Bother.” J Urol, 165:1521-25,
2001.
Taylor, JMG, Cooper, K, Wei, J, Sarma, A, Raghunathan, T, Heeringa, S: “Use of Multiple
Imputation to Correct for Nonresponse Bias in a Survey of Urologic Symptoms among
African-American Men”. Am J Epidemiol, 156: (8) 774-782, 2002.
Taub, DA, Hollenbeck, BK, Cooper, KL, Dunn, RL, Miller, DC, Taylor, JMG, Wei, JT:
“Racial Disparities in Resource Utilization for Cystectomy.” Urology, 67(2): 288-93,
2006.
Pennathur A, Luketich JD, Landreneau RJ, Ward J, Christie NA, Schuchert M, Cooper
K, Land SR, Belani CP: “Long-Term Results of a Phase II Trial of Neoadjuvant Chemotherapy
Followed by Esophagectomy for Locally Advanced Esophageal Neoplasm,” Annals of Thoracic
Surgery 85: 1930-1937, 2008.
Yildiz-Aktas IZ, Dabbs DJ, Cooper KL, Chivukula, M, McManus K, Bhargava, R: "The Effect
of 96-Hour Formalin Fixation on the Immunohistochemical Evaluation of Estrogen Receptor,
Progesterone Receptor, and HER2 Expression in Invasive Breast Carcinoma" Am J Clin
Pathol (Accepted)
Jankowitz RC, Cooper KL, Erlander MG, Ma XJ, Kesty NC, Li H, Chivukula M, Brufsky
A, “Prognostic utility of the breast cancer index and comparison to Adjuvant.” Online
in a clinical case series of early breast cancer. Breast Cancer Research 13:R98, 2011
Dawson, LA, Biersack, MP, Schipper, MJ, Ten Haken, RT: “A novel approach to evaluate
partial volume-dose-complication relationships.”- ABSTRACT. Int J Radiat Oncol Biol
Phys, 54: (2), Supplement 1, 127-128, 2002.
Miller, C, Lin, L, Moy, J, Schipper, M, Normolle, D, Brenner, D, Iannettoni, M, Orringer,
M, Beer, D: “Gene amplification in esophageal adenocarcinomas and Barrett's with high-grade
Dysplasia.” Clin Cancer Res, 9: 4819-4825, 2003.
Dawson, LA, Saito, NG, Ratanatharathorn, V, Uberti, JP, Adams, PT, Ayash, LJ, Reynolds,
CM, Silver, SM, Schipper, MJ, Lichter, AS, Eisbruch, A: “Phase I study of involved-field
radiotherapy preceding autologous stem cell transplantation for patients with high-risk
lymphoma or Hodgkin's disease.” Int J Radiat Oncol Biol Phys, 59(1), 208-218, 2004.
Eisbruch, A, Marsh, L, Dawson, L, Bradford, C, Teknos, T, Chepeha, D, Worden, F, Urba,
S, Lin, A, Schipper, M, Wolf, G: “Recurrences near base of Skull After IMRT of Head
and Neck Cancer: Implications for Target Delineation in High Neck and for Parotid
Sparing.” Int J Rad Onc Biol Phys, 59: 28-42, 2004.
Krueger E, Schipper M, Koelling T, Marsh R, Butler J, Pierce L: “Cardiac Chamber and
Coronary Artery Doses Associated with Postmastectomy Radiotherapy Techniques to the
Chest Wall and Regional Nodes.” Int J Radiat Oncol Biol Phys, 60(4): 1195-203, 2004.
Suh W, Schott A, Hayman J, Schipper M, Shewach D, Pierce L: “A phase I Dose Escalation
Trial of Gemcitabine with Radiotherapy for Breast Cancer in the Treatment of Unresectable
Chest Wall Recurrences.” Breast J, 10: 204-210, 2004.
Feng M, Jabbari S, Lin A, Bradford C, Chepeha D, Teknos T, Worden F, Tsien C, Schipper
M, Wolf G, Dawson L, Eisbruch A: “Predictive factors of local-regional recurrences
following IMRT for head and neck cancer.” ABSTRACT, Intl J Radiat Oncol Biol Phys,
60: S506-S507, 2004.
Feng M, Jabbari S, Lin A, Bradford CR, Chepeha DB, Teknos TN, Worden FP, Tsien C,
Schipper MJ, Wolf GT, Dawson LA and Eisbruch A: “Predictive factors for loco-regional
(LR) failures after intensity modulated radiotherapy (IMRT) for head and neck (HN)
cancers.” Radiotherapy and Oncology 2005; 77: 32-8.
Hayman, JA, Kabeto, MU, Schipper, MJ, Bennett, JE, Vicini, FA, Pierce, LJ: “Assessing
the Benefit of Radiation Therapy After Breast-Conserving Surgery for Ductal Carcinoma-In-Situ.”
J Clin Oncol, 23: (22), 5171-5177, 2005.
Kong, FM, Ten Haken, RK, Schipper, MJ, Sullivan, MA, Chen, M, Lopez, C, Kalemkerian,
GP, Hayman, JA: “High-dose radiation improved local tumor control and overall survival
in patients with inoperable/unresectable non-small-cell lung cancer: Long-term results
of a radiation dose escalation study.” Int J Radiat Oncol Biol Phys, 63: (2), 324-33,
2005.
Lin, A, Jabbari, S, Worden, FP, Bradford, CR, Chepeha, DB, Teknos, TN, Liao, JJ, Nyquist,
G, Tsien, C, Schipper, MJ, Urba, S, Wolf, GT, Eisbruch, A: “Metabolic abnormalities
associated with weight loss during chemo-irradiation of head and neck cancer.” Int
J Radiat Oncol Biol Phys, 63(5):1413-18, 2005.
Khan, MK, Mamou, F, Schipper, MJ, Kwitney, A, Warnat, A, Nair, B, Kariapper, MS, Brewer,
G, Normolle, D, Merajver, S, Teknos, T: “The combination of Tetrathiomolybdate (TM)
and radiation therapy in an in vivo mouse tumor model of head and neck squamous cell
carcinoma (HNSCC).” Arch Otolaryngol Head Neck Surg, 132(3): 333-8, 2006.
Mamou, F., May, K., Schipper, M., Gill, N., Kariapper, M., Nair, B., Brewer, G., Normolle,
D., Khan, M. “Tetrathiomolybdate Blocks bFGF- but not VEGF- induced Incipient Angiogenesis.“
In Vitro, Anticancer Research 26: 1753-1758, 2006.
Meirovitz A, Murdoch-Kinch CA, Schipper M, Pan C and Eisbruch A. Grading xerostomia
by physicians or by patients after intensity-modulated radiotherapy of head-and-neck
cancer. Int J Radiation Oncology Biology Physics 66(2): 445-53, 2006.
Schipper, MJ, Taylor, JMG, Lin, X: “Bayesian Generalized Monotonic Functional Mixed
Models for the Effects of Radiation Dose Histograms on Normal Tissue Complications.”
Statistics in Medicine, 26(25) 4643-56, 2007.
Nandalur KR, Hardie AD, Raghavan P, Schipper MJ, Baskurt E, Kramer CM. Composition
of the Stable Carotid Plaque: Insights from a Multidetector computed tomography study
of plaque volume. Stroke ,38(3):935-40, 2007.
Dillman JR, Caoili EM, Cohan RH, Ellis JH, Francis IR and Schipper MJ. Detection of
upper tract urothelial neoplasms: Sensitivity of axial, coronal reformatted, and curved-planar
reformatted image-types utilizing 16-row multi-detector CT urography. Abdominal Imaging,
33(6):707-16, 2008.
Khan MK, Minc LD, Nigavekar SS, Kariapper MST, Nair BM, Schipper MJ, Cook AC, Lesniak
WG and Balogh LP. Fabrication of {198Au0} radioactive composite nanodevices and their
use for nanobrachytherapy. Nanomedicine: Nanotechnology, Biology, and Medicine , 4(1):
57-69, 2008
Sundaram B, Gross BH, Martinez FJ, Oh E, Müller NL, Schipper M, Kazerooni EA: “Accuracy
of High-Resolution CT in the Diagnosis of Diffuse Lung Disease: Effect of Predominance
and Distribution of Findings.” Am. J. Roentgenol., 191: 1032–1039, 2008
Soto DE, Glaser S, Roberts RH, Schipper MJ, McLaughlin PW, Ray ME, SandlerHM, Pan
CC (2008). Impact of common iliac nodal treatment on radiation outcomes in localized
prostate cancer. Urology 71; 313-317.
Quint LE, Cheng J, Schipper MJ, Chang A, Kalemkerian G: “Lung Lesion Doubling Times:
Values and Variability Based on Method of Volume Determination.” J Clin Radiol, 63(1):
41-8, 2008.
Rufener SL, Patel S, Kazerooni EA, Schipper MJ and Kelly AM. Comparison of on-callradiology
resident and faculty interpretation of 4 and 16-row multidetector CT pulmonary angiography
with indirect CT venography. Academic Radiology , 15(1) 71-6, 2008.
Schipper, MJ, Taylor, JMG, Lin, X: “Generalized Monotonic Functional Mixed Models
with Application to Modeling Normal Tissue Complications.” Applied Statistics, 57(2),
149-163, 2008
Sisson JC, Schipper MJ, Nelson CC, Freitas JE and Frueh BR. Radioiodine therapy and
Graves’ Eye Disease. Journal of Nuclear Medicine 2008; 49(6): 923-30.
Agarwal P, Patel S, Corbett J, Jung JI, Barber K, Schipper MJ, and Kazerooni EA (2009).
Left ventricular functional analysis with 16 and 64-row multidetector CT: comparison
with gated SPECT. Journal of Computer Assisted Tomography 33(1): 8-14.
Goodsitt MM, Chan HP, Way TW, Schipper MJ, Larson SC and Christodoulou EG (2009) Quantitative
CT of lung nodules: dependence of calibration on patient body size, lung size and
calibration nodule size for single- and dual-energy techniques. Medical Physics, 36(7):
3107-3121.
Sheikh K, Schipper MJ and Hoeffner EG (2009) Feasibility of superficial temporal artery
as input artery in cerebral CT perfusion. American Journal of Roentgenology, 192(6):W321-9.
Sundaram B, Miller C, Schipper MJ, Cohan RH and Francis IR (2009) Can CT features
diagnose surgical adult bowel intussusceptions? American Journal of Roentgenology,
193(2): 471-8.
Pabon-Ramos W, Caoili E, Cohan R, Stephens T, Francis I, Ellis J, Korobkin M and Schipper
M. Excretory urography: trends in clinical use and diagnostic yield. Abdominal Imaging.
2009 Jun 27. [Epub ahead of print]
Caoili EM, Cohan RH, Ellis JH, Dillman J, Schipper MJ, Francis IR (2009) Medical decision
making regarding computed tomographic radiation dose and associated risk: the patient's
perspective. Arch Intern Med, 169(11):1069-71.
Chen NG, Fowlkes JB, Carson PL, Schipper MJ and LeCarpentier GL. Rapid 3D imaging
of contrast flow: Application to perfused kidney vasculature. Ultrasound in Medicine
& Biology 2009; 35(5):813-28.
Ash L, Schipper MJ and Mukherji SK. The Utricular Macula: qualitative and quantitative
analysis using 3T imaging. Journal of Computer Assisted Tomography 2010 Jan;34(1):93-7.
Deiterle F, Sistare F, Goodsaid F, Schipper MJ, Mattes W: (2010) “Renal Biomarker
Qualification Submission: A dialog between the FDA/EMEA and PSTC.” Nature Biotechnology,
28(5): 455-62.
Sistare F, Goodsaid F, Schipper MJ, Yu Y (2010) Towards establishing good biomarker
qualification practices for new kidney safety biomarkers in early drug development
and regulatory decision-making. Nature Biotechnology, 28(5): 446-54.
Pai D, Willat JM, Korobkin M, Cohan RH, Ellis JH, Francis IR, Wolf JS and Schipper
MJ (2010) CT appearances following laparoscopic partial nephrectomy for renal cell
carcinoma using a rolled cellulose bolster.” Cancer Imaging, 2010, 10:161-8.
Dewaraja YK, Schipper MJ, Roberson PL, Wilderman SJ, Regan D, Amro H, Koral KF, Kaminski
MS and Avram AM (2010) Dosimetry of I-131 tositumomab radioimmunotherapy: tumor dose-response
using measures from 3-dimensional calculation including radiobiologic modeling. Journal
of Nuclear Medicine, 51(7): 1155-62.
Roberson PL, Amro H, Wilderman SJ, Avram AM, Kaminski MS, Schipper MJ and Dewaraja
YK. Using an Equivalent Uniform Dose Model to Categorize Response to Therapy for Patients
with Non-Hodgkin’s Lymphoma. Medical Physics. (Accepted).
Holder, D and Schipper, MJ. Statistical issues in biomarker research. In: Biomarkers
in Medicine, Drug Discovery and Environmental Health, edited by Vishal Vaidya and
Joseph Bonventre, John Wiley and Sons, New York, Chapter 24; 2010.
Tsien CI, Brown D, Normolle D, Schipper M, Morand P, Junck L, Heth JA, Gomez-Hassan
D, Ten-Haken R, Chenevert TL, Cao Y, Lawrence TS: "Concurrent Temozolomide and Dose-Escalated
Intensity Modulated Radiation Therapy in Newly Diagnosed Glioblastoma." Clin Cancer
Res. 2011 Nov 7. Epub ahead of print PMID:22065084
Little M, Schipper M, Feng FY, Vineberg K, Cornwall C, Murdoch-Kinch CA, Eisbruch
A: "Reducing Xerostomia After Chemo-IMRT for Head-and-Neck Cancer: Beyond Sparing
the Parotid Glands." Int J Radiat Oncol Biol Phys. 2011 Nov 4. Epub ahead of print
PMID:22056067
Halverson S, Schipper M, Blas K, Lee V, Sabolch A, Olson K, Sandler HM, Feng FY, Hamstra
DA : "The Cancer of the Prostate Risk Assessment (CAPRA) in patients treated with
external beam radiation therapy: Evaluation and optimization in patients at higher
risk of relapse." Radiother Oncol. 2011 Dec;101(3):513-20. Epub 2011 Jun 22. PMID:21703711
PubMed - in process
Roberson PL, Amro H, Wilderman SJ, Avram AM, Kaminski MS, Schipper MJ, Dewaraja YK:
"Bio-effect model applied to 131I radioimmunotherapy of refractory non-Hodgkin's lymphoma."
Eur J Nucl Med Mol Imaging. 2011 May;38(5):874-83. Epub 2010 Dec 21. PMID:21174088
Schipper MJ, Koral KF, Avram AM, Kaminski MS, Dewaraja YK: “Prediction of therapy
tumor absorbed dose estimates in I-131 radioimmunotherapy using tracer data via a
mixed model fit to time-activity.” Cancer Biotherapy & Radiopharmaceuticals, (accepted)
Cooper GS, Johnson CC, Lamerato L, Poisson LM, Schultz L, Simpkins J, Wells K, Yood
MU, Chase G, Nathanson SD, Lafta JE: “Use of Guideline Recommended Follow-Up Care
in Cancer Survivors: Routine or Diagnostic Indications?” Medical Care, 44: 590-594,
2006.
Lafata JE, Simpkins J, Lamerato L, Poisson L, Divine G, Johnson CC. The economic impact
of false-positive cancer screens.Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2126-32.
Poisson LM, Ghosh D: “Statistical issues and analyses of in vitro and in vivo genomic
data in order to identify clinically relevant profiles.” Cancer Informatics, 1: 231-243,
2007. PMCID: PMC2600568
Ghosh, D, Poisson LM (2009) "Omics" data and levels of evidence for biomarker discovery.”
Genomics, 93:13-16
Patwa TH, Li C, Poisson LM, Kim HY, Pal M, Ghosh D, Simeone DM, Lubman DM (2009) The
Identification of Phosphoglycerate kinase-1 (PGK-1) and Histone H4 Auto-Antibodies
in Pancreatic Cancer Patient Serum Using a Natural Protein Microarray. Electrophoresis.
Jun;30(12):2215-26. PMID: 19582723
Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro
RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh
D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher
C, Chinnaiyan AM (2010) Response to: Jentzmik, F. et al. Sarcosine in Urine after
Digital Rectal Examination Fails as a Marker in Prostate Cancer Detection and Identification
of Aggressive Tumors.” Eur urol 2010;58:12-8., European urology 2010;58(3):e29-30.
Khan AP, Poisson LM, Bhat V, Fermin D, Zhao R, Nesvizhskii AI, Omenn GS, Chinnaiyan
AM, Sreekumar A: (2010) “Quantitative Proteomic Profiling of Prostate Cancer Reveals
a Role for miR-128 in Prostate Cancer.” Molecular and Cellular Proteomics, 9: 298-312,
PMID: 19955085
Sreekumar A, Poisson LM, Cao Q, Rajendiran TM, Varambally S, Lonigro RJ, Li Y, Cao
X,
Nyati MK, Kalyana-Sundaram S, Mehra R, Ahsan A, Vellaichamy A, Byun J, Han B, Omenn
GS,
Ghosh D, Wei JT, Pennathur S, Berger A, Beecher C, Chinnaiyan AM (2009) “Metabolomic
Profiling of Prostate Cancer Progression.” Nature, 475:910-14
Poisson LM, Taylor JMG, Ghosh D: “Integrative set enrichment testing for multiple
omics platforms.” BMC Bioinformatics 2011, 12:459
Jain R, Poisson L, Narang J, Scarpace L, Rosenblum ML, Rempel S, Mikkelsen T, "Correlation
of Perfusion Parameters with Genes Related to Angiogenesis Regulation in Glioblastoma:
A Feasibility Study" Am J Euroradiology (accepted)
Deng H, Zwetchkenbaum S, Noone A. "Bond strength of silicone to polyurethane following
immersion of silicone in cleaning solutions." J Prosthetic Dentistry, 91(6): 582-5,
2004.
Kroon HM, Li Q, Teitz-Tennenbaum S, Whitfield JR, Noone AM, Chang AE: “4-1BB Co-stimulation
of Effector T Cells for Adoptive Immunotherapy of Cancer: Involvement of Bcl Gene
Family Members. Journal of Immunotherapy, 30; 406-16, 2006.
Simon MS, Banerjee M, Crossley-May H, Vigneau FD, Noone AM, Schwartz K: “Racial Differences
in Breast Cancer Survival in the Detroit Metropolitan Area.” Breast Cancer Research
and Treatment, 97; 149-55, 2006.
Banerjee M, Noone AM. Tree-Based Methods for Survival Data. Statistical Advances in
Biomedical Sciences: State of the Art and Future Directions (Eds. M. Segal, S. Datta,
J. Fine). 265-285, 2008.
Movva S, Noone AM, Banerjee M, Patel D, Schwartz K, Yee CL, Simon MS: “Racial Differences
in Cervical Cancer Survival in the Detroit Metropolitan Area.” Cancer, 112(6):1264-71,
2008.
Noone AM, Banerjee M. Machine Learning Methods for Cancer Diagnosis and Prognostication.
Computational Methods in Biochemical Research (Eds. R. Khattree, D. Naik). 77-101,
Chapman & Hall: Boca Raton, FL, 2008.
Wu RR, Lindenberg PA, Slack RS, Noone AM, Marshall JL, He AR (2009). Evaluation of
Hypertension as a Marker of Bevacizumab Efficacy. Journal of Gastrointestinal Cancer,
40(3-4);101-8.
Liu MC, Shields PG, Warren RD, Cohen P, Wilkinson M, Ottaviano YL, Rao SB, Eng-Wong
J, Seillier-Moiseiwitch F, Noone AM, Isaacs C (2009). Circulating tumor cells: A Useful
Predictor of Treatment Efficacy in Metastatic Breast Cancer. Journal of Clinical Oncology,
27(31);5153-9.
Yan B, Noone AM, Yee C, Banerjee M, Schwartz K, Simon MS (2009). Racial Differences
in Colorectal Cancer Survival in the Detroit Metropolitan Area. Cancer, 115(16); 3791-800.
Aiello AE, Diez-Roux A, Noone AM, Ranjit N, Cushman M, Tsai MY, Szklo M (2009). Socioeconomic
and Psychosocial Gradients in Cardiovascular Pathogen Burden and Immune Response:
The Multi-Ethnic Study of Atherosclerosis. Brain, Behavior, and Immunity, 23(5); 663-71.
Broustas CG, Ross JS, Yang Q, Sheehan CE, Riggins RB, Cavalli LR, Haddad BR, Seillier-Moiseiwitsch
F, Noone AN, Kallakury BVS, Haffty BG, Clarke R, and Kasid UN. (2010) The Pro-apoptotic
Molecule BLID Interacts with Bcl-XL, and its Downregulation in Breast Cancer Correlates
with Poor Disease Free and Overall Survival.” Clin Can Res, 16(11):2939-48.
Ahmadi N, Goldman R, Seillier-Moiseiwitsch F, Noone AM, Kosti O, Davidson BJ. (2010)
“Decreased Risk of Squamous Cell Carcinoma of the Head and Neck in Users of Non-steroidal
Anti-inflammatory Drugs.” Intl J Otolaryngology, 424161.
Mandelblatt JS, Sheppard VB, Hurria A, Kimmick G, Isaacs C, Taylor K, Kornblith AB,
Noone AM, Luta G, Tallarico M, Barry WT, Hunegs L, Zon R, Naughton M, Winer E, Hudis
C, Edge SB, Cohen HJ, Muss H (2010) Breast Cancer Adjuvant Chemotherapy Decisions
in Older Women: The Role of Patient Preference and Interactions with Physicians. J
Clin Oncol, 28(19):3146-53.
Sen A, Banerjee M, Li Y, Noone AM (2010): “A Bayesian Approach to Competing Risks
Analysis with Masked Cause of Death.” Stats in Med, 29(16): 1681-95.
Unger KR, Lominska CE, Deeken JF, Davidson BJ, Newkirk KA, Gagnon GJ, Noone AM, Slack
RS, Harter KW (2010). Fractionated Stereotactic Radiosurgery for Reirradiation of
Head and Neck Cancer.” Intl J Radiat Oncol Biol Phys, 77(5): 1411-9.
MacLaughlin BW, Wang D, Liu N, Noone AM, Harazduk N, Lumpkin M, Haramati A, Saunders
P, Dutton M, Amri H (2010). “Stress Biomarkers in Medical Students Participating in
a Mind Body Medicine Skills Program.” Evidence Based Complementary and Alternative
Medicine, doi:10.1093/ecam/neq039.
Dyba M, Wang A, Noone AM, Goerlitz D, Shields P, Zheng Y-L, Chung FL: “Metabolism
of isothiocyanates in individuals with positive and null GSTM1 and T1 genotypes after
drinking watercress juice.” Clinical Nutrition, 29(6): 813-8, 2010.
Wycherly BJ, Berkowitz F, Noone AM, Kim HJ: “Computed Tomography and Otosclerosis:
A Practical Method to Correlate the Sites Affected to Hearing Loss.” Ann Otol Rhinol
Laryngol, 119:789-794, 2010.
Banerjee M, Ding Y, Noone AM: “Identifying Representative Trees in Random Forest for
Survival Data.” Accepted to Stat Med, 2011.
Wallington SF, Luta G, Noone AM, Caicedo L, Lopez-Class M, Sheppard V, Spencer C,
Mandelblatt J: “Assessing the awareness of and willingness to participate in cancer
clinical trials among immigrant Latinos.” J Comm Health, Epub ahead of print, 2011.
Cavalli LR, Noone AM, Makambi KH, Rone JD, Kasid UN, Haddad BR: “Loss of the BLID
Tumor Suppressor Gene in Early-Onset Breast Cancer.” Cytogenetic and Genome Research,
135(1):19-24, 2011.
Shi, HR, Fessler, JA: “Quadratic regularization design for fan beam transmission tomography.”
Proc. SPIE 5747, Medical Imaging: Image Proc., pp. 2023-33, 2005.
Fessler, JA, Lee, S, Olafsson, VT, Shi, HR, Noll, DC: “Toeplitz-based iterative image
reconstruction for MRI with correction for magnetic field inhomogeneity.” IEEE Trans.
Sig. Proc., 53(9):3393-402, 2005.
Shi, HR, Fessler, JA: “Quadratic regularization design for 3d cylindrical PET.” Proc.
IEEE Nuc. Sci. Symp. Med. Im. Conf, 4: 2301-5, 2005.
Shi, HR, Fessler, JA: “Quadratic regularization design for 3D axial CT.” Proc. IEEE
Nuc. Sci. Symp. Med. Im. Conf., pp. 2834-6, 2006.
Shi HR, Fessler JA: “Quadratic regularization design for 2D CT.” IEEE Trans. Med.Imag.,
28(5):645-56, 2009.
Kirkoriani Y, Siskind J, Marmur E. Perioperative Management of Anticoagulant Therapy
during Cutaneous Surgery: 2005 Survey of Mohs Surgeons. Dermatologic Surgery, 33(10):
1189-97, 2007.
Galvez MP, Morland K, Raines C, Kobil J, Siskind J, Godbold J, Brenner B: “Race and
Food Sore Availability in an Inner-City Neighborhood.” Public Health Nutr, 11(6):
624-31, 2008.
Frame B, Stuart L. Beal, Raymond Miller, Jeannette Barrett and Paula Burger, “Mixed
effects modeling of weight change associated with placebo and pregabalin administration”,
J Pharmacokinet Pharmacodyn, 2007, 34(6):753-70.
Frame B, Miller R, Hutmacher MM: “Joint modeling of dizziness, drowsiness, and dropout
associated with pregabalin and placebo treatment of generalized anxiety disorder”,
J Pharmacokinet Pharmacodyn, 2009, 36(6):565-84.
Lee IH, Roberts R, Shah RB, Wojno KJ, Wei JT, Sandler HM: “Perineural invasion is
a marker for pathologically advanced disease in localized prostate cancer.” Intl J
Radiat Oncol, Biol, Phys, 68:1059-1064, 2007.
Profit J, McCormick MC, Escobar GJ, Richardson DK, Zheng Z, Coleman-Phox K, Roberts
R, Zupancic JAF (2007) “Neonatal Intensive Care Unit Census Influences Discharge of
Moderately preterm Infants.” Pediatrics 119: 314-319.
Soto DE, Andridge R, Pan CC, Williams S, Taylor J, Sandler HM: “Determining if pretreatment
PSA doubling time predicts PSA trajectories after radiation therapy for localized
prostate cancer.” Radiotherapy and Oncology, 90; 389-394, 2008.
Soto, DE, Andridge, R, Pan, CC, Williams, S, Taylor, JMG, Sandler, HM: “In Patients
Experiencing Biochemical Failure after Radiation Therapy Pretreatment Risk Group and
PSA Velocity Predict Differences in Overall Survival and Biochemical Failure Free
Interval.” Intl J Radiat Oncol Biol Phys, 71:1295-1301, 2008.
Soto DE, Glaser S, Roberts RH, Schipper MJ, McLaughlin PW, Ray ME, Sandler HM, Pan
CC (2008). Impact of common iliac nodal treatment on radiation outcomes in localized
prostate cancer. Urology 71; 313-317.
Soto DE, Andridge RR, Taylor JMG, McLaughlin PW, Sandler HM, Pan CC: “Predicting biochemical
failure and overall survival through intra-therapy PSA changes during definitive external
beam radiation.” Intl J Radiat Oncol, Biol, Phys, 72; 1408-1415, 2008.
Taylor JMG, Ankerst DP, Andridge RR: “Validation of Biomarker-based Risk Prediction
Models.” Clin Can Res, 14:5977-83, 2008.
Andridge RR, Little RJA (2009). The use of sample weights in hot deck imputation.
Journal of Official Statistics 25; 21-36, NIHMS#299472.
Clark N, Dodge J, Houle C, Thomas L, Andridge R, Awad D, Payton J (2010) Asthma in
10 to 13 year olds: Challenges at a time of transition. Clinical Pediatrics; In press.
Andridge RR, Little RJA (2010). A Review of Hot Deck Imputation for Survey Nonresponse.
International Statistical Review 78; 40-64, NIHMS#299474.
Clark N, Dodge J, Shah S, Thomas L, Andridge R, Awad D (2010). A Current Picture of
Asthma Diagnosis, Severity, Control In A Low Income Minority Preteen Population. Journal
of Asthma 47; 150-155.
Clark N, Shah S, Dodge J, Thomas L, Andridge R, Little R (2010). An evaluation of
asthma interventions for preteen students. Journal of School Health 80; 80-87.
Andridge RR, Little RJA (2011) Proxy Pattern-Mixture Analysis for Survey Nonresponse.
Journal of Official Statistics, in press.
Andridge RR (2011) “Quantifying the impact of fixed effects modeling of clusters in
multiple imputation for cluster randomized trials.” Biometrical Journal, 53; 57-74,
NIHMS#298223.
Fagundes CP, Glaser R, Johnson SL, Andridge RR, Yang EV, Di Gregorio MP, Chen M, Lambert
DR, Jewell SD, Bechtel MA, Hearne DW, Herron JB, Kiecolt-Glaser JK (2011). Basal cell
carcinoma: Stressful life events and the tumor environment. Arch Gen Psychiatry, Formally
accepted.
Glaser R, Andridge RR, Yang EV, Arwa S, DiGregorio MP, Chen M, Johnson SL, DeRenne
L, Lambert DR, Jewell SD, Bechtell MA, Hearne DW, Herron JB, Kiecolt-Glaser JK (2011).
Immune markers associated with risk for subsequent basal cell carcinomas. PLoS ONE
6(9): e25160. doi:10.1371/journal.pone.0025160
Kiecolt-Glaser JK, Belury MA, Andridge R, Malarkey WB, Glaser R (2011).Omega-3 supplementation
lowers in ammation and anxiety in medical students: A randomized controlled trial.
Brain, Behavior, and Immunity, 25; 1725-1734.
Rhoda DA, Murray DM, Andridge RR, Pennell ML, Hade EM (2011). Studies with staggered
starts: Multiple baseline designs and group-randomized trials. American Journal of
Public Health 101; 2164-2169.
Shojaie A, Michailidis G (2009) “Analysis of Gene Sets Based on the Underlying Regulatory
Network.” J Computational Biol, 16(3): 407-26.
Shojaie A, Michailidis G (2010) Network Enrichment Analysis in Complex Experiments,
Stat App Genetics Mol Biology,9(1): Article22, 2010.
Shojaie A, Michailidis G (2010) Penalized Likelihood Methods for Estimation of Sparse
High Dimensional DAGs, Biometrika, 97(3):519-538.
Shojaie A, Michailidis: “ Discovering graphical Granger causality using the truncating
lasso penalty.” Bioinformatics, 26(18):i517-i523, 2010.
Putluri N, Shojaie A, Vasu V, Nalluri S, Vareed S, Putluri V, Vivekanandan-Giri A,
Creighton C, Byun J, Pennathur S, Sana T, Fischer S, Michailidis G, Sreekumar A: “Metabolomic
Profiling Reveals A Role for Androgen in Activating Amino Acid Metabolism and Methylation
in Prostate Cancer Cells.” PLoS One, 2011, 6(7):e21417.
Putluri N, Shojaie A, Vasu V, Vareed S, Nalluri S, Putluri V, Tallman C, Butler C,
Sana S, Fischer S, Sica G, Brat D, Shi H, Weizer A, Terris M, Shariat S, Michailidis
G, Sreekumar A: “Metabolomic Profiling Reveals Potential Markers and Mechanism for
Bladder Cancer Progression.” Cancer Research, In Press, 2011.
Basu S, Shojaie A, Michailidis G: “Estimating Regulatory Networks from Time Course
Gene Expression Data via Adaptive Penalization.” Proceedings of NIPS Workshop on Machine
Learning in Computational Biology, Accepted, 2011
Franzblau A, Kazerooni EA, Sen A, Goodsitt MM, Lee SY, Rosenman KD, Lockey JE, Meyer
CA. Gillespie BW, Petsonk EL, Wang ML (2009). Comparison of digital radiographs with
film gradiographs for the classification of pneumoconiosis. Acad Radiol. Jun;16(6):669-77
Brand RE, Greer JB, Zolotarevsky E, Brand R, Du H, Simeone D, Zisman A, Gorchow A,
Lee SY, Roy HK, Anderson M (2009). Pancreatic cancer patients who smoke and drink
are diagnosed at younger ages. Clin Gastroenterol Hepatol. Sep;7(9):1007-12
Sen A, Lee SY, Gillespie BW, Kazerooni EA, Goodsitt MM, Rosenman KD, Lockey JE, Meyer
CA. Petsonk EL, Wang ML, Franzblau A (2010). Comparison of reliability of classification
for pneumoconiosis of film and digital radiographs: a modeling approach. Acad Radiol.
Apr;17(4):511-19
Gulati RM, Wever EM, Tsodikov A, Penson D, Inoue LY, Katcher J, Lee SY, Heijnsdijk
EA, Draisma G, De Koning HJ, Etzioni R: “What if I don’t Treat my PSA-Detected Prostate
Cancer? Answers from Three Natural History Models.” Cancer Epidemiology Biomarkers
& Prevention, in press, 2011
Pujana MA, Han JJ, Starita LM, Stevens KN , Tewari M, Ahn JS , Rennert G, Moreno V,
Assmann V, ElShamy WM, Rual JF, Rozek LS, Gelman RS, Gunsalus KC, Greenberg RA, Sobhian
B, Bertin N, Venkatesan K, Ayivi-Guedehoussou N, Lázaro C, Nathanson KL, Weber BL,
Cusick ME, Hill DE, Livingston DM, Gruber SB, Parvin JD, Vidal M, Network modeling
links breast cancer susceptibility and centrosome dysfunction, Nature Genet, 39, 1338-1349,
2007.
Stevens KN, Hakonarson H, Kim C, Doevendans P, Koeleman BPC, Mital S, Raue J, Glessner
J, Coles JG, Moreno V, Granger A, Gruber SB , Gruber PJ: “Common variation in ISL1
confers genetic susceptibility for human congenital heart disease.” PLoS One, 5(5):
e10855, 2010.
Castellsagué E, González S, Guinó E, Stevens KN, Borràs E, Raymond VM, Lázaro C, Blanco
I, Gruber SB, Capellá G: “Allele-specific expression of APC in adenomatous polyposis
families.” Gastroenterology 139(2):439-47, 2010.
Segui N, Stevens KN, Guin E, Rozek LS, Moreno V, Capella G, Gruber SB, Valle L: “No
differences in germline allele-specific expression of TGFBR1 between colorectal cancer
patients and controls.” Br J Cancer, 104(4):735-40 2011.
Stevens KN, Wang X, Fredericksen Z, Pankratz VS, Vachon CM, Olson JE, Couch FJ: “Evaluation
of associations between common variation in mitotic regulatory pathways and risk of
overall and high grade breast cancer.” Breast Cancer Res Treat, 129(2):617-22, 2011.
Stevens KN, Vachon CM, Lee AM, Slager S, Lesnick T, Olswold C, Fasching PA, Miron
P, Eccles D, Carpenter JE, Godwin AK, Ambrosone C, Winqvist R, Brauch H on behalf
of the GENICA consortium, Schmidt MK, Cox A, Cross S, Sawyer E, Hartmann A, Beckmann
MW, Schulz-Wendtland R, Ekici AB, Tapper WJ, Gerty SM, Durcan L, Graham N, Hein R,
Nickels S, Flesch-Janys D, Heinz J, Sinn HP, Konstantopoulou I, Fostira F, Pectasides
D, Dimopoulos AM, Fountzilas G, Clarke CL, Balleine R, Olson JE, Fredericksen Z, Diasio
RB, Pathak H, Ross E, Weaver J, Rüdiger T, Försti A, Dünnebier T, Ademuyiwa F, Kulkarni
S, Pylkäs K, Jukkola-Vuorinen A, Ko YD, Van Limbergen E, Janssen H, Peto J, Fletcher
O, Giles GG, Baglietto L, Verhoef S, Tomlinson I, Kosma VM, Beesley J, Greco D, Blomqvist
C, Irwanto A, Liu J, Blows FM, Dawson SJ, Margolin S, Mannermaa A, Martin NG, Montgomery
GW, Lambrechts D, dos Santos Silva I, Severi G, Hamann U, Pharoah P, Easton DF, Chang-Claude
J, Yannoukakos D, Nevanlinna H, Wang X, Couch FJ: “Common breast cancer susceptibility
loci are associated with triple negative breast cancer.” Cancer Research 71(19):6240-6249
2011.
Stevens KN, Garcia-Closas M, Fredericksen Z, Kosel M, Pankratz VS, Hopper JL, Dite
GS, Apicella C, Southey MC, Schmidt MK, Broeks A, Van ’t Veer LJ, Tollenaar RAEM,
Fasching PA, Beckmann MW, Hein A, Ekici AB, Johnson N, Peto J, dos Santos Silva I,
Gibson L, Sawyer E, Tomlinson I, Kerin MJ, Chanock S, Lissowska J, Hunter DJ, Hoover
RN, Thomas GD, Milne RL, Arias Pérez JI, González-Neira A, Benítez J, Burwinkel B,
Meindl A, Schmutzler RK, Bartrar CR, Hamann U, Ko YD, Brüning T, the GENICA Network,
Chang-Claude J, Hein R, Wang-Gohrke S, Dörk T, Schürmann P, Bremer M, Hillemanns P,
Bogdanova N, Zalutsky JV, Rogov YI, Antonenkova N, Lindblom A, Margolin S, Mannermaa
A, Kataja V, Kosma VM, Hartikainen J, Chenevix-Trench G, Chen X, kConFab Investigators,
Australian Ovarian Cancer Study Group, Peterlongo P, Bonanni B, Bernard L, Manoukian
S, Wang X, Cerhan J, Vachon CM, Olson JE, Giles GG, Baglietto L, McLean CA, Severi
G, John EM, Miron A, Winqvist R, Pylkäs R, Jukkola-Vuorinen A, Grip M, Andrulis I,
Knight JA, Glendon G, Mulligan AM, Cox A, Brock IW, Elliott G, Cross SS, Pharoah PP,
Dunning AM, Pooley KA, Humphreys MK, Wang J, Kang D, Yoo KY, Noh DY, Sangrajrang S,
Gabrieau V, Brennan P, McKay J, Anton-Culver H, Ziogas A, Couch FJ, Easton DF: “Evaluation
of variation in the phosphoinositide-3-kinase catalytic subunit alpha (PIK3CA) oncogene
and breast cancer risk.” Br J Cancer 2011 Oct 27 [Epub ahead of print].
Haiman CA, Chen GK, Vachon CM, Canzian F, Dunning A, Millikan RC, Wang X, Ademuyiwa
F, Ahmed S, Ambrosone CB, Baglietto L, Balleine R, Bandera EV, Beckmann MW, Berg CD,
Bernstein L, Blomqvist C, Blot WJ, Brauch H, Buring JE, Carey LA, Carpenter JE, Chang-Claude
J, Chanock SJ, Chasman DI, Clarke CL, Cox A, Cross SS, Deming SL, Diasio RB, Dimopoulos
AM, Driver WR, Dünnebier T, Durcan L, Eccles D, Edlund CK, Ekici AB, Fasching PA,
Feigelson HS, Flesch-Janys D, Fostira F, Försti A, Fountzilas G, Gerty SM, The GENICA
Consortium, Giles GG, Godwin AK, Goodfellow P, Graham N, Greco D, Hamann U, Hankinson
SE, Hartmann A, Hein R, Heinz J, Holbrook A, Hoover RN, Hu JJ, Hunter DJ, Ingles SA,
Irwanto A, Ivanovich J, John EM, Johnson N, Jukkola-Vuorinen A, Kaaks R, Ko YD, Kolonel
LN, Konstantopoulou I, Kosma VM, Kulkarni S, Lambrechts D, Lee AM, Le Marchand L,
Lesnick T, Liu J, Lindstrom S, Mannermaa A, Margolin S, Martin NG, Miron P, Montgomery
GW, Nevanlinna H, Nickels S, Nyante S, Olswold C, Palmer J, Pathak H, Pectasides D,
Perou CM, Peto J, Pharoah P, Pooler L, Press MF, Pylkäs K, Rebbeck TR, Rodriguez-Gil
JL, Rosenberg L, Ross E, Rüdiger T, dos Santos Silva I, Sawyer E, Schmidt MK, Schulz-Wendtland
R, Schumacher F, Severi G, Sheng X, Signorello LB, Sinn HP, Stevens KN, Southey MC,
Tapper WJ, Tomlinson I, Hogervorst FBL, Wauters E, Weaver J, Wildiers H, Winqvist
R, Van Den Berg D, Wan P, Xia LY, Yannoukakos D, Zheng W, Ziegler RG, Siddiq A, Slager
SL, Stram DO, Easton DF, Kraft P, Henderson BE, Couch FJ: “A susceptibility locus
for estrogen receptor negative breast cancer subtypes at 5p15 (TERT).” Nat Genet 2011
Oct 30 Epub ahead of print]
King CA, Kerr DCR, Passarelli MN, Foster CE, Merchant CR. One-year follow-up of suicidal
adolescents: Parent history of mental health problems and time to post-hospitalization
attempt. J Youth and Adolescence, 2010; 39(3): 219-232.
Beasley JM, Newcomb PA, Trentham-Dietz A, Hampton JM, Bersch AJ, Passarelli MN, Holick
CN, Titus-Ernstoff L, Egan KM, Holmes MD, Willett WC: “Post-diagnosis dietary factors
and survival after invasive breast cancer.” Breast Cancer Res Treat. 2011 Jan 1. Epub
ahead of print
Coghill AE, Newcomb PA, Chia VM, Zheng Y, Wernli KJ, Passarelli MN, Potter JD: “Pre-diagnostic
NSAID use but not hormone therapy use is associated with survival after a diagnosis
of colorectal cancer in women.” Br J Cancer, 2011, 104(5):763-8.
Soto DE, Passarelli MN, Daignault S, Sandler HM: “Concurrent androgen deprivation
therapy during salvage prostate radiotherapy improves treatment outcomes in high-risk
patients.” Int J Radiat Oncol Biol Phys 2011 May 5. (Epub ahead of print)
Passarelli MN, Coghill AE, Hutter CM, Zheng Y, Makar KW, Potter JD, Newcomb PA: “Common
colorectal cancer risk variants in SMAD7 are associated with survival among prediagnostic
nonsteroidal anti-inflammatory drug users: A population-based study of postmenopausal
women.” Genes Chromosomes Cancer. 2011 Nov;50(11):875-86.
Adams SV, Passarelli MN, Newcomb PA” “Cadmium exposure and cancer mortality in the
third National Health and Nutrition Examination Survey cohort.” Occup Environ Med.
2011 (In Press)
Zhang J, Lee J, Urba S, Foster J, Worden F. A phase II trial evaluating weekly docetaxel
and capecitabine in patients with metastatic or advanced, locally recurrent head and
neck cancers. Cancer Invest, 28(9):910-916, 2010, PMID:20590443.
Foster, JC, Taylor, JMG, and Ruberg, SJ. Subgroup identification from randomized clinical
trial data. Stats in Med, 30(24):2867-2880, 2011, PMCID:PMC3880775.
Foster JC, Taylor JMG, Nan B. Variable selection in monotone single-index models via
the adaptive LASSO. Stat Med, 32(22):3944-3954, 2013, PMCID:PMC3773259
Mason H, DeRubeis MB, Foster JC, Taylor JMG, Worden FP. Outcomes evaluation of a weekly
nurse practitioner-managed symptom management clinic for patients with head and neck
cancer treated with chemoradiotherapy. Oncol Nurs Forum, 40(6):581-586, 2013, PMCID:PMC4764379.
Waterman JM, Nadeem E, Paczkowski E, Foster JC, Lavner JA, Belin T, Miranda J. Pre-placement
risk and longitudinal cognitive development for children adopted from foster care.
Child Welfare, 92(4):9-30, 2013, PMCID:PMC4772770.
Foster JC, Taylor JMG, Kaciroti N, Nan B. Simple subgroup approximations to optimal
treatment regimes from randomized clinical trial data. Biostatistics, 16(2):368-382,
2015, PMCID:PMC5006409.
Taylor JMG, Cheng W, Foster JC. Reader reaction to a robust method for estimating
optimal treatment regimes by Zhang et al. (2012). Biometrics, 71(1):267-271, 2015,
PMCID:PMC4768908.
Foster JC, Nan B, Shen L, Kaciroti N, Taylor JMG. Permutaton testing for treatment-covariate
interactions and subgroup identification. Statistics in Bioscience, 8(1):77-98, 2016,
PMCID:PMC5010868.
Sanchez BN, Raghunathan TE, Diez Roux AV, Zhu Y, Lee O (2008) Combining data from
primary and ancillary surveys to assess the association between neighborhood-level
characteristics and health outcomes: the Multi-Ethnic Study of Artherosclerosis. Statistics
in Medicine. November;27(27):5745-4763
Chen G, Kim S, Taylor JMG, Wang Z, Lee O, Ramnath N, Reddy RM, Lin J, Chang AC, Orringer
MB, Beer DG: “Development and Validation of a qRT-PCR Classifier for Lung Cancer Prognosis.”
Journal of Thoracic Oncology, in press, 2011.
Lee O, Braun TM: “Permutation tests for random effects in linear mixed models.” Biometrics,
68(2) 486-93, 2012
Chapman CH, Nazem-Zadeh M, Lee OE, Schipper MJ, Tsien Cl, Lawrence TS, Cao Y: "Regional
Variation in Brain White Matter Diffusion Index Changes following Chemoradiotherapy:
A Prospective Study Using Tract-Based Spatial Statistics." PLoS One, 8(3): e57768,
2013
Lao C, Friedman J, Tsien Cl, Normolle DP, Chapman C, Cao Y, Lee OE, Schipper M, VanPoznak
C, Hamstra D, Lawrence T, Hayman J and Redman B: "Concurrent whole brain radiotherapy
and bortezomib for brain metastasis." Radiation Oncology 2013; 8(1): 204, PMC3765365.
Liu E, Stenmark M, Schipper MJ, Balter JM, Kessler ML, Caoili EM, Lee OE, Ben-Josef
E, Lawrence TS and Feng M: "Stereotactic Body Radiation Therapy for Primary and Metastatic
Liver Tumors." Transl Oncol. 2013; 6(4): 442-446.
Hunter KU, Lee OE, Lyden TH, Haxer MJ, Feng FY, Schipper MJ, Worden F, Prince ME,
McLean MA, Wolf GT, Bradford CR, Chepeha DA and Eisbruch A. Aspiration pneumonia after
Chemo-lMRT of oropharyngeal carcinoma and its clinical and dysphagia-related predictors.
Head and Neck, 36:120-125, 2014, PMCID:PMC4144677.
Rischin D, Spigel DR, Adkins D, Wein R, Arnold S, Singhal N, Lee O, Murugappan S.
PRISM: Phase 2 trial with panitumumab monotherapy as second-line treatment in patients
with recurrent or metastatic squamous cell carcinoma of the head and neck. Head Neck,
Suppl 1:E1756-1761, 2016. PMID:26681429.
Wilson RH, Chandra M, Scheiman JM, Lee SY, Lee OE, McKenna BH, Simeone DM, Taylor
JM, Mycek MA. Tissue classification using optical spectoscopy accurately differentiates
cancer and chronic pancreatitis. Pancreas, 46(2):244-251, 2017, PMCID:PMC5235923.
Kennedy EH, Taylor JMG, Schaubel DE, Williams SG: “The effect of salvage therapy on
survival in a longitudinal study with treatment by indication.” Stats in Med, 29(25):
2569-2580, 2011, PMC2962719.
Fakih MG, Watson SR, Greene MT, Kennedy EH, Olmsted R, Krein SL, Saint S: “Promoting
patient safety by reducing inappropriate urinary catheter use: a statewide effort
in Michigan.” Arch Int. Med, (to appear)
Fakih MG, Greene MT, Kennedy EH, Meddings JA, Krein SL, Olmsted R, Saint S: “Introducing
a population-based outcome measure to evaluate the effect of interventions to reduce
catheter-associated urinary tract infection.” Am J Infect Control, in press, 2011.
Shuman AG, Yang Y, Taylor JM, Prince ME. End-of-life care among head and neck cancer
patients. Otolaryngol Head Neck Surg, 144(4), 2011, PMCID:PMC3879721.
Yang Y, Little R. A Comparison of doubly robust estimators of the mean missing data.
Journal of Statistical Computation and Simulation, 85(16):3383-3403, 2015.
Chen Q, Elliott MR, Haziza D, Yang Y, Ghosh M, Little RJA, Sedransk J, Thompson M.
Approaches to improving survey-weighted estimates. Statistical Science, 32(2): 227-248,
2017.
Shuman AG, Entezamil P, Chernin AS, Wallace NE, Taylor JMG, Hogikyan NDDemographics
and efficacy of head and neck cancer screening, Otolaryngology - Head and Neck Surgery,
2010, 143(3):353-60, PMID: 20723771
Conlon A, Taylor JMG, Sargent D, Yothers G: “Using Cure Models and Multiple Imputation
to Utilize Recurrence as an Auxiliary Variable for Overall Survival.” Clin Trials;
J Society for Clin Trials, 8(5): 581-90, 2011, NIHMS #309264.
Hamstra DA, Daignault S, Conlon ASC, Dunn RL, Sandler HM, Hembroff AL, Zietman AL,
Kaplan I, Ciezki J, Kuban D, Wei JT, Sanda MG, Michalski J, and the PROSTQA Consortium
Study Group: "Multi-Institutional Prospective Evaluation of Bowel Quality of Life
After Prostate External Beam Radiation Therapy Identifies Patient and Treatment Factors
Associated with Patient Reported Outcomes: The PROSTQA Experience". Intl J Radiat
Oncol Biol Physics, 86(3):546-53, 2013
Sabel MS, Terjimanian M, Conlon ASC, Griffith KA, Morris AM, Mulholland MW, Englesbe
MJ, Holcombe S, Wang SC: "Analytic Morphometric Assessment of Patients Undergoing
Colectomy for Colon Cancer." J Surg Oncol, 108:169-175, 2013
Conlon ASC, Taylor JMG, Elliott MR: "Surrogacy Assessment Using Principal Stratification
When Surrogate and Outcome Measures are Multivariate Normal." Biostatistics. 15(2):266-83,
2014
Conlon ASC, Taylor JMG, Sargent DJ: "Multi-State Models for Colon Cancer Recurrence
and Death with a Cured Fraction." Stat Med, 33(10):1750-66, 2014
Stenmark MH, Conlon ASC, Johnson S, Daignault S, Litzenberg D, Marsh R, Ritter T,
Vance S, Kazzi N, Feng F, Sandler H, Sanda MG, Hamstra DA: "Dose to the inferior rectum
is strongly associated with patient reported bowel quality of life after radiation
therapy for prostate cancer." Radiat Oncol, 110(2):291-7, 2014
Conlon ASC, Taylor JMG, Sargent DJ, Yothers G: "Improving Efficiency in Clinical Trials
Using Auxiliary Information; Application of a Multi-State Cure Model." Biometrics,
71(2):460-8, 2015
Elliott M, Conlon ASC, Li Y, Kaciroti N, Taylor JMG: "Surrogacy Marker Paradox Measures
in Meta-Analytic Settings". Biostatistics, 16(2):400-12, 2015
Taylor JMG, Conlon ASC, Elliott MR: "Surrogacy Assessment Using Principal Stratification
with multivariate normal and Gaussian Copula Models." Clinical Trials, 12(4):317-22,
2015
Levy H, Seydafkan S, Rice JD, Easley KA, Tangpricha V: Comparative efficacy of vertebroplasty,
kyphoplasty, and medical therapy for vertebral fractures on survival and prevention
of recurrent fractures". Endocrine Practice 18, 499-507, 2012
Sabel MS, Rice JD, Griffith KA, Lowe L, Wong SL, Chang AE, Johnson TM, Taylor JMG:
“Validation of Statistical Predictive Models Meant to Select Melanoma Patients for
Sentinel Lymph Node Biopsy.” Annals of Surgical Oncology, 19(1:297-93, 2012.
Li S, Mukherjee B, Taylor JMG, Rice KM, Wen X, Rice JD, Stringham HM, Boehnke M: "The
role of environmental heterogeneity in meta-analysis of gene environment interactions
with quantitative traits". Genetic Epidemiology 38, 416-429, 2014
Rice JD, Taylor JMG: “Locally Weighted Score Estimation for Quantile Classification
in Binary Regression Models” Statistics in Bioscience, in press, 2016
Estes JP, Rice JD, Li S, Stringham HM, Boehnke M, Mukherjee B. Meta-analysis of gene-environment
interaction exploiting gene-environment independence across multiple case-control
studies. Stat Med, 36(24):3895-3909, 2017, PMCID:PMC5624850.
Rice JD, Tsodikov A. Semiparametric profile likelihood estimation for continuous outcomes
with excess zeros in a random-threshold damage-resistance model. Stat Med, 36(12):1924-1935.
2017, PMCID:PMC5530377.
Rice JD, Tsodikov A. Semiparametric time-to-event modeling in the presence of a latent
progression event. Biometrics, 73(2):463-472, 2017, PMCID:PMC5325816.
Roca H, Craig MJ, Ying C, Varsos ZS, Czarnieski P, Alva AS, Hernandez J, Fuller D,
Daignault Newton S, Healy PN, Pienta KJ. IL-4 induces proliferation in prostate cancer
PC3 cells under nutrient-depletion stress through the activation of the JNK-pathway
and surviving up-regulation. J Cell Biochem. 113(5): 1569-80, 2012, PMC3337359.
Jorns, J, Visscher D, Sabel M, Breslin T, Daignault-Newton S, Healy PN, Myers J, Wu
A. lntraoperative frozen section analysis of margins in breast conserving surgeries
significantly decreases re-operative rates: one year experience at an outpatient surgery
center Amer J Clin Path, 138(5):657-69, 2012
Arps DP, Healy PN, Zhao L, Kleer CG and Pang JC:" Invasive ductal carcinoma with lobular
features: a comparison study to invasive ductal and invasive lobular carcinomas of
the breast." Breast Cancer Res Treat, 138(3):719-26, 2013
Jorns JM, Healy PN, Zhao L: " Review of Estrogen Receptor, Progesterone Receptor,
and HER-2/neu lmmunohistochemistry Impacts on Treatment for a Small Subset of Breast
Cancer Patients Transferring." Arch Pathol Lab Med137(11):1660-3, 2013
Roca H, Hernandez J, Weidner S, McEachin RC, Fuller D, Sud S, Schumann T, Wilkinson
JE, Zaslavsky A, Li H, Maher CA, Daignault-Newton, Healy PN, Pienta KJ: "Transcription
Factors OVOL 1 and OVOL2 Induce the Mesenchymal to Epithelial Transition in Human
Cancer." PloS One, 8(10): e76773, 2013
O'Malley M, Healy PN, Daignault S, Ramnath N: "Cigarette Smoking and Gemcitabine-lnduced
Neutropenia in Advanced Solid tumors." Oncology , 85(4) :216-22, 2013.
Jorns JM, Thomas DG, Healy PN, Daignault S, Vickery TL, Snider JE, Mardis ER, Davies
SR, Ellis MJ, Visscher DW. Estrogen receptor expression is high but is of lower intensity
in tubular carcinoma than in well-differentiated invasive ductal carcinoma. Arch Pathol
Lab Med, 138(11):1507-13, 2014, PMCID:PMC4327939
Boonstra PS, Gruber SB, Raymond VM, Huang SC, Timshel S, Nilbert M and Mukherjee B.
A review of statistical methods for testing genetic anticipation: Looking for an answer
in Lynch syndrome. Genetic Epidemiology, 34(7)756-768, 2010, PMCID:PMC3894615
Boonstra PS, Mukherjee B, Taylor JMG, Nilbert M, Moreno V and Gruber SB. Bayesian
modeling for genetic anticipation in presence of mutational heterogeneity: A case-study
in hereditary non-polyposis colorectal cancer (Lynch syndrome). Biometrics, 67(4):1627-1637,
2011, PMCID:PMC3176998.
Boonstra PS, Mukherjee B, Taylor JMG. Bayesian shrinkage methods for partially observed
data with many predictors. Ann Appl Stat, 7(4):2272-2292, 2013, PMCID:PMC3891514.
Boonstra PS, Taylor JMG and Mukherjee B. Incorporating auxiliary information for improved
prediction in high dimensional datasets: An ensemble of shrinkage approaches. Biostatistics,
14(2):259-272, 2013, PMCID:PMC3590922.
Boonstra PS, Bondarenko I, Park SK, Vokonas PS and Mukherjee B. Propensity score-based
diagnostics for categorical response regression models. Statistics in Medicine 33(3):455-469,
2014, PMCID:PMC3911784.
Stenzel SL, Ahn J, Boonstra PS, Gruber SB, and Mukherjee B. The impact of exposure-biased
sampling designs on detection of gene-environment interactions in case-control studies
with potential exposure misclassification. European Journal of Epidemiology 30(5):413-423,
2015, PMCID:PMC4256150.
Boonstra PS, Mukherjee B, Taylor JMG. A small-sample choice of the tuning parameter
in ridge regression. Stat Sin, 25(3):1185-1206, 2015, PMC:PMC4790465.
Boonstra PS, Shen J, Taylor J, Braun TM2, Griffith KA, Daignault S, Kalemkerian GP,
Lawrence TS, Schipper MJ. A statistical evaluation of dose expansion cohorts in phase
I clinical trials. J Natl Cancer Inst, 107(3). pii: dju429, 2015, PMCID:PMC4565529.
Boonstra PS, Taylor JMG, Mukherjee B. Adaptive shrinkage via the hyperpenalized EM
algorithm. Stat Biosci, 7(2):417-431, 2015, PMCID:PMC4728141.
Stenzel SL, Ahn J, Boonstra PS, Gruber SB, and Mukherjee B. The impact of exposure-biased
sampling designs on detection of gene-environment interactions in case-control studies
with potential exposure misclassification. Eur J Epidemiol, 30(5):413-423, 2015, PMCID:PMC4256150.
Boonstra PS, Mukherjee B, Gruber SB, Ahn J, Schmit SL, and Chatterjee N. Tests for
gene-environment interactions and joint effects with exposure misclassification. Am
J Epidemiol, 83(3):237-247, 2016, PMCID:PMC4724093.
Boonstra PS, Taylor JMG and Mukherjee B. Increasing efficiency for estimating treatment-biomarker
interactions with historical data. Stat Methods Med Res, 25(6):2959-2971, 2016, PMCID:PMC5450810.
Boonstra PS, Taylor JM, Smolska-Ciszewska B, Behrendt K, Dworzecki T, Gawkowska-Suwinska
M, Bialas B, Suwinski R. Alpha/beta (α/β) ratio for prostate cancer derived from external
beam radiotherapy and brachytherapy boost. Br J Radiol, 89(1061):20150957, 2016, PMCID:PMC4985475.
Taylor JMG, Cheng W, Foster JC. Reader reaction to a robust method for estimating
optimal treatment regimes by zhang et al. Biometrics, 71(1):267-271, 2015, PMCID:PMC4768908.
Cheng W, Taylor JMG, Mukherjee B, Vokonas P, Park SK. Improving estimation in linear
regression incorporating external information from an established reduced model. Stat
Med, 37(9):1515-1530, 2018, PMCID:PMC5889759.
Cheng W, Taylor JMG, Gu T, Tomlins SA, Mukherjee B. informing a risk prediction model
for binary outcomes with external coefficient information. Journal of the Royal Statistical
Society Series C, 68(1):121-139, 2019, PMCID:PMC6519970.
Gu T, Taylor JMG, Cheng W, Mukherjee B. Synthetic data method to incorporate external
information into a current study. Canadian Journal of Statistics, 47(4):580-603, 2019,
PMCID:PMC7410329.
Haymart MR, Muenz DG, Stewart AK, Griggs JJ, Banerjee M. Disease Severity and Radioactive
Iodine Use for Thyroid Cancer. J Clin Endocrin Metab, 98(2):678-686, 2013, PMCID:PMC3565122.
Banerjee M, Muenz DG, Chang JT, Papaleontiou M, Haymart MR. Tree-based model for thyroid
cancer prognostication. J Clin Endocrin & Metabol, 99(10):3737-3745, 2014, PMCID:PMC4184064.
Banerjee M, Muenz DG, Worden F, Wong SL, Haymart MR. Conditional survival in patients
with thyroid cancer. Thyroid, 24(14):1784-1789, 2014, PMCID:PMC4267546.
Wiebal JL, Banerjee M, Muenz DG, Worden FP, Haymart MR. Trends in imaging after diagnosis
of thyroid cancer. Cancer, 121(9):1387-1394, 2015, PMCID:PMC4409471.
Banerjee M, Lao CD, Wancata LM, Muenz DG, Haymart MR, Wong SL. Implications of age
and conditional survival estimates for patients with melanoma. Melanoma Res, 26(1):77-82,
2016, PMCID:PMC5020374.
Wancata LM, Banerjee M, Muenz DG, Haymart MR, Wong SL. Conditional survival in advanced
colorectal cancer and surgery. J Surg Res, 201(1):196-201, 2016, PMCID:PMC4744618.
Rosko AJ, Birkeland AC, Wilson KF, Muenz DG, Bellile E, Bradford CR, McHugh JB, Spector
ME. Tumor biomarkers in spindle cell variant squamous cell carcinoma of the head and
neck. Otolaryngol Head Neck Surg, 155(1):106-112, 2016, PMCID:PMC4930715.
Meraj TS, Muenz DG, Glazer TA, Harvey RS, Spector ME, Hoff PT. Does drug-induced sleep
endoscopy predict surgical success in transoral robotic multilevel surgery in obstructive
sleep apnea? Laryngoscope, 127(4):971-976, 2017, PMID:27796047.
Muenz DG, Braun T, Taylor JMG. Modeling adverse event counts in phase I clinical trials
of a cytotoxic agent. Clinical Trials, 15(4):386-397, 2018, PMCID:PMC6053332.
Scott GB, Brogly SB, Muenz D, Stek AM, Read JS. International Maternal Pediatric Adolescent
AIDS Clinical Trials Group (IMPAACT) P1025 Study Team: Missed opportunities for prevention
of mother-to-child transmission of human immunodeficiency virus. Obstet Gynecol, 129(4):621-628,
2017, PMCID:PMC6122962.
Muenz DG, Taylor JMG, Braun T. Phase I-II trial design for biologic agents using conditional
auto-regressive models for toxicity and efficacy. Journal of the Royal Statistical
Society, 68(2)331-345, 2018, doi.org/10.1111/rssc.12314.
Manohar PM, Beesley LJ, Taylor JM, Hesseltine E, Haymart MR, Esfandiari NH, Hanauer
DA, Worden FP. Retrospective study of sirolimus and cyclophosphamide in patients with
advanced differentiated thyroid cancers. J Thyroid Disord Ther, 4(3):188, 2015, PMCID:PMC4831630.
Janz NK, Li Y, Beesley LJ, Wallner LP, Hamilton AS, Morrison RA, Hawley ST. Worry
about recurrence in a multi-ethnic population of breast cancer survivors and their
partners. Support Care Cancer, 24(11):4669-4678, 2016, PMCID:PMC7821383.
Beesley LJ, Bartlett JW, Wolf GT, Taylor JM. Multiple imputation of missing covariates
for the Cox proportional hazards cure model. Stat Med, 35(26):4701-4717, 2016, PMCID:PMC5053880.
Sawyer ME, Evans MV, Wilson CA, Beesley LJ, Leon LS, Eklund CR, Croom EL, Pegram RA.
Development of a human physiologically based pharmacokinetic (PBPK) model for dermal
permeability for lindane. Toxicol Lett, 245:106-109, 2016, PMID:267994662.
Birkeland AC, Rosko AJ, Beesley L, Bellile E, Chinn SB, Shuman AG, Prince ME, Wolf
GT, Bradford CR, Brenner JC, Spector ME. Preoperative tracheostomy is associated with
poor disease-free survival in recurrent laryngeal cancer. Otolaryngol Head Neck Surg,
157(3):432-438, 2017, PMCID:PMC5593767.
Birkeland AC, Beesley L, Bellile E, Rosko AJ, Hoesli R, Chinn SB, Shuman AG, Prince
ME, Wolf GT, Bradford CR, Brenner JC, Spector ME. Predictors of survival after total
laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma. Head Neck,
39(12):2512-2518, 2017, PMCID:PMC5686454.
Schmitd LB, Beesley LJ, Russo N, Bellile EL, Inglehart RC, Liu M, Romanowicz G, Wolf
GT, Taylor JMG, D'Silva NJ. Redefining perineural invasion: integration of biology
with clinical outcome. Neoplasia, 20(7):657-667, 2018, PMCID:PMC6030236.
Hoban CW, Beesley LJ, Bellile EL, Sun Y, Spector ME, Wolf GT, Taylor JMG, Shuman AG.
Individualized outcome prognostication for patients with laryngeal cancer. Cancer,
124(4):706-716, 2018, PMCID:PMC5800991.
Manohar PM, Beesley LJ, Bellile EL, Worden FP, Avram AM. Prognostic Value of FDG-PET/CT
metabolic parameters in metastatic radioiodine-refractory differentiated thyroid cancer.
Clin Nucl Med, 43(9):641-647, 2018, PMCID:PMC6076335.
Beesley LJ, Hawkins PG, Amlani L, Bellile EL, Casper KA, Chinn SB, Eisbruch A, Mierzwa
ML, Spector ME, Wolf GT, Shuman AG, Taylor JMG. Individualized survival prediction
for patients with oropharyngeal cancer in the human papillomavirus era. Cancer, 125(1):
68-78, 2019, PMCID:PMC6309492.
Beesley LJ, Morgan TM, Spratt DE, Singhal U, Feng FY, Furgal AC, Jackson WC, Daignault
S, Taylor JMG. Individual and population comparisons of surgery and radiotherapy outcomes
in prostate cancer using bayesian multistate models. JAMA Netw Open, 2(2):e187765,
2019, PMCID:PMC6484613.
Fritsche LG, Beesley LJ, VandeHaar P, Salvatore M, Zawistowski M, Gagliano SA, Das
S, LeFaive J, Kaleba EO, Klumpner TT, Moser SE, Blanc VM, Brummett CM, Kheterpal S,
Abecasis GR, Gruber SB, Mukherjee B: Exploring various polygenic risk scores for basal
cell carcinoma, cutaneous squamous cell carcinoma and melanoma in the phenomes of
the Michigan Genomics Initiative and the UK Biobank. PLOS Genetics, 15(6):e1008202,
2019, PMCID:PMC6592565.
Taylor JMG, Shuman AG, Beesley LJ. Individualized prognostic calculators in the precision
oncolory era. Oncotarget, 10(4):415-416, 2019, PMCID:PMC6355181.
Beesley LJ, Taylor JMG. EM algorithms for fitting multistate cure models. Biostatistics,
20(3):416-432, 2019, PMCID:PMC6659172.
Wallner LP, Li Y, Furgal AKC, Friese CR, Hamilton AS, Ward KC, Jagsi R, Katz SJ, Hawley
ST. Patient preferences for primary care provider roles in breast cancer survivorship
care. Clin Oncol, 35(25):2942-2948, 2017, PMCID:PMC5575964.
Furgal AKC, Sen A, Taylor JMG: Review and comparison of computational approaches for
joint longitudinal and time-to-event models. International Statistical Review, 87(2):393-418,
2019, PMCID:PMC7009936.
Beesley LJ, Morgan TM, Spratt DE, Singhal U, Feng FY, Furgal AC, Jackson WC, Daignault
S, Taylor JMG. Individual and population comparisons of surgery and radiotherapy outcomes
in prostate cancer using bayesian multistate models. JAMA Netw Open, 2(2):e187765,
2019, PMCID:PMC6484613.
Radhakrishnan A, Li Y, Furgal AKC, Hamilton AS, Ward KC, Jagsi R, Katz SJ, Hawley
ST, Wallner LP. Provider involvement in care during initial cancer treatment and patient
preferences for provider roles after initial treatment. Journal of Oncology Practice,
15(4):e328-e337, 2019, PMCID:PMC6550057.
Mahmoudi E, Kamdar N, Furgal A, Sen A, Zazove P, Bynum J. Potentially preventable
hospitalizations among older adults: 2010-2014. Ann Fam Med, 18(6):511-519, 2020,
PMCID:PMC7708283.
Arnedt JT, Conroy DA, Mooney A, Furgal A, Sen A, Eisenberg D. Telemedicine versus
face-to-face delivery of cognitive behavioral therapy for insomnia: a randomized controlled
noninferiority trial. Sleep, 44(1):zsaa136, 2021, PMID:32658298.
Hertz DL, Caram MV, Kidwell KM, Thibert JN, Gersch C, Seewald NJ, Smerage J, Rubenfire
M, Henry NL, Cooney KA, Leja M, Griggs JJ, Rae JM. Evidence for association of SNPs
in ABCB1 and CBR3, but not RAC2, NCF4, SLC28A3 or TOP2B, with chronic cardiotoxicity
in a cohort of breast cancer patients treated with anthracyclines. Pharmacogenomics,
17(3):231-40, 2016, PMCID:PMC5558515.
Kadakia KC, Snyder CF, Kidwell KM, Seewald NJ, Flockhart DA, Skaar TC, Desta Z, Rae
JM, Otte JL, Carpenter JS, Storniolo AM, Hayes DF, Stearns V, Lynn Henry N. Patient-reported
outcomes and early discontinuation in aromatase inhibitor-treated postmenopausal women
with early stage breast cancer. Oncologist, 21(5):539-46, 2016, PMCID:PMC4861358.
Hertz DL, Kidwell KM, Seewald NJ, Gersch CL, Desta Z, Flockhart DA, Storniolo AM,
Stearns V, Skaar TC, Hayes DF, Henry NL, Rae JM. Polymorphisms in drug-metabolizing
enzymes and steady-state exemestane concentration in postmenopausal patients with
breast cancer. Pharmacogenomics J, 17(6):521-527, 2017, PMCID:PMC532433.
Kadakia KC, Kidwell KM, Seewald NJ, Snyder CF, Storniolo AM, Otte JL, Flockhart DA,
Hayes DF, Stearns V, Henry NL. Prospective assessment of patient-reported outcomes
and estradiol and drug concentrations in patients experiencing toxicity from adjuvant
aromatase inhibitors. Breast Cancer Res Treat, 164(2):411-419, 2017, PMCID:PMC5517133.
Meurer WJ, Seewald NJ, Kidwell K. Sequential multiple assignment randomized trials:
an opportunity for improved design of stroke reperfusion trials. J Stroke Cerebrovasc
Dis, 26(4):717-724, 2017, PMCID:PMC5362332.
Kidwell KM, Seewald NJ, Tran Q, Kasari C, Almirall D. Design and analysis considerations
for comparing dynamic treatment regimens with binary outcomes from sequential multiple
assignment randomized trials. Journal of Applied Statistics, 45(9): 1628-1651, 2017,
PMCID: PMC6290190.
Hertz DL, Henry NL, Kidwell KM, Thomas D, Goddard A, Azzouz F, Speth KA, Li L, Banerjee
M, Thibert JN, Kleer CG, Stearns V, Hayes DF, Skaar TC, Rae JM. ESR1 and PGR Polymorphisms
Affect Estrogen and Progesterone Receptor Expression in Breast Tumors. Physiological
Genomics, 48(9):688-698, 2016, PMCID:PMC5111879.
Bhave MA, Speth KA, Kidwell KM, Lyden A, Alsamarraie C, Murphy SL, Henry NL. Effect
of aromatase inhibitor therapy on sleep and daytime activity patterns in early stage
breast cancer. Clinical Breast Cancer, 18(2):68-174, 2017, PMCID:PMC6203440.
Hertz DL, Speth KA, Kidwell KM, Gersch CL, Desta Z, Storniolo AM, Stearns V, Skaar
TC, Hayes DF, Henry NL, Rae JM. Variable aromatase inhibitor plasma concentrations
do not correlate with circulating estrogen concentrations in post-menopausal breast
cancer patients. Breast Cancer Research Treatment, 165(3):659-668, 2017, PMCID:PMC5709190.
Henry NL, Speth KA, Lintermans A, Kidwell KM, Carlson R, Hayes DF, Neven P. Associations
between patient and anthropometric characteristics and aromatase inhibitor discontinuation.
Clinical Breast Cancer, 17(5):350-355, 2017, PMCID:PMC5537010.
Kung TA, Kidwell KM, Speth KA, Pang JC, Jagsi R, Newman LA, Wilkins EG, Momoh AO.
Radiation-Induced skin changes after postmastectomy radiation therapy: A pilot study
on indicators for timing of delayed breast reconstruction. Journal of Reconstructive
Microsurgery, 35(3):209-215, 2018, PMID:30231269.
Beeler WH, Speth KA, Broderick MT, Jairath NK, Ballouz D, Gharzai LA, Jackson WC,
Kim MM., Owen D., Szerlip NJ, Paradis KC, Spratt DE. Local control and toxicity of
multi-level spine stereotactic body radiosurgery. Neurosurgery, 86(2):E164-E172, 2019,
PMID: 31541240.
Morishita M, Wang L, Speth K, Zhou N, Bard RL, Brook JR, Rajagopalan S, Brook RD.
Acute cardiovascular effects of near-roadway exposures with and without N95-Respirators.
American Journal of Hypertension, 32(11):1054-1065, 2019, PMCID:PMC7962899.
Billig JI, Speth KA, Nasser JS, Wang L, Chung KC. Assessment of surgeon variation
in adherence to evidence-based recommendations for treatment of trigger finger. JAMA
Network Open, 2(10):e1912960, 2019, PMCID:PMC6804023.
Speth K, Wang L. Restricted sub-tree learning to estimate an optimal dynamic-treatment
regime using observational data. Stat Med, 40(26):5796-5812, 2021.
Speth K, Yoon AP, Wang L, Chung KC. Assessment of tree-based statistical learning
to estimate optimal personalized treatment decisions rules for traumatic finger amputations.
JAMA Open Network, 3(2):e1921626-e1921636, 2020.
van Die MD, Williams SG, Emery J, Bone KM, Taylor JM, Lusk E, Pirotta MV. A placebo-controlled
double-blinded randomized pilot study of combination phytotherapy in biochemically
recurrent prostate cancer. Prostate, 77(7):765-775, 2017, PMCID:PMC5444299
Qin A, Lusk E, Daignault-Newton S, Schneider B. Chemotherapy and Radiation Versus
Chemotherapy Alone for Elderly Patients With N3 Stage IIIB NSCLC. Clin Lung Cancer,
20(4):e495-e503, 2019, PMCID:PMC6629485.
Gottschlich A, Nuntadusit T, Zarins KR, Hada M, Chooson N, Bilheem S, Navakanitworakul
R, Nittayaboon K, Virani S, Rozek L, Sriplung H & Meza R. Barriers to cervical cancer
screening and acceptability of HPV self-testing: a cross-sectional comparison between
ethnic groups in Southern Thailand. BMJ Open, 9(11):e031957, 2019, PMCID:PMC6858097.
Murchland AR, Gottschlich A, Bevilacqua K, Pineda A, Sandoval-Ramírez BA, Alvarez
CS, Ogilvie GS, Carey TE, Prince N, Dean M, Mendoza-Montano C, Rivera-Andrade A & Meza
R. HPV self-sampling acceptability in rural and indigenous communities in Guatemala:
a cross-sectional study. BMJ Open, 9:e029158, 2019, PMCID:PMC6830827.
Gottschlich A, Rivera-Andrade A, Bevilacqua K, Murchland AR, Isak E, Alvarez CS, Ogilvie
G, Carey TE, Prince M, Dean M, Mendoza-Montano C, Meza R. Using self-collection HPV
testing to increase engagement in cervical cancer screening programs in rural Guatemala:
a longitudinal analysis. BMC Public Health, 20(1):1406, 2020, PMCID:PMC72493167.
Gottschlich A, Mus S, Monzon JC, Thrasher JF, Barnoya J. Cross-sectional study on
the awareness, susceptibility and use of heated tobacco products among adolescents
in Guatemala City, Guatemala. BMJ Open, 10(12):e039792, 2020, PMCID:PMC7737060.
Gottschlich A, van Niekerk D, Smith LW, Gondara L, Melnikow J, Cook DA, Lee M, Stuart
G, Martin RE, Peacock S, Franco EL, Coldman A, Krajden M, Ogilvie G. Assessing 10-Year
safety of a single negative HPV test for cervical cancer screening: Evidence from
FOCAL-DECADE Cohort. Cancer Epidemiol Biomarkers Prev, 30(1):22-29, 2020, PMCID:PMC8284866.
Gottschlich A, Ochoa P, Rivera-Andrade A, Alcarez CS, Mendoza-Montano C, Camel C & Meza
R. Barriers to cervical cancer screening in Guatemala: A quantitative analysis using
data from the guatemala demographic and health surveys. International Journal of Public
Health, 65(2):217-226, 2020, PMCID:PMC7049547.
East EG, Gast KM, Kuzon WM Jr, Roberts E, Zhao L, Jorns JM. Clinicopathological findings
in female-to-male gender-affirming breast surgery. Histopathology,71(6):859-865, 2017,
PMID: 28657118.
Muller KE, Roberts E, Zhao L, Jorns JM. Isolated atypical lobular hyperplasia diagnosed
on breast biopsy: Low upgrade rate on subsequent excision with long-term follow-up.
Arch Pathol Lab Med, 2018 Mar;142(3):391-395, 2017, PMID:29160721.
East E, Gabbeart M, Roberts E, Zhao L, Jorns J. A rapid triage protocol to optimize
cold ischemic time for breast resection specimens. Annals of Diagnostic Pathology,
34:94-97, 2018, PMID:29661737.
Geer M, Roberts E, Shango M, Till B, Smith S, Abbas H, Hill B., Kaplan J, Barr PM,
Caimi PF, Stephens DM, Lin E, Herrera AF, Rosenbaum E, Amengual K, Boonstra PS, Devata
S, Wilcox RA, Kaminski M, and Phillips T. Multicentre retrospective study of intravascular
large B‐cell lymphoma treated at academic institutions within the United States. British
journal of haematology, 186(2):255-262, 2019, PMCID:PMC8989046.
Needham BL, Salerno S, Roberts E, Boss J, Allgood KL, Mukherjee B. Do black/white
differences in telomere length depend on socioeconomic status? Biodemography Soc Biol,
65(4):287-312, 2019, PMCID:PMC7703670.
East E, Roberts E, Zhao L, Jorns J. Repeat biomarker status in breast resection specimens
with controlled cold ischemic time. American Journal of Clinical Pathology. 152(6):766-774,
2019, PMID:31338514.
Siontis BL, McHugh JB, Roberts E, Zhao L, Thomas DG, Owen D, Baker LH, Biermann JS,
Schuetze SM, Chugh R. Differential outcomes and biologic markers of radiation-associated
vs. sporadic osteosarcoma: A single-institution experience. Front Oncol, 9:1523, 2019,
PMCID:PMC6987384.
Hanks JE, Kovatch KJ, Ali SA, Roberts E, Durham AB, Smith JD, Bradford CR, Malloy
KM, Boonstra PS, McKean SA. Sentinel lymph node biopsy in head & neck melanoma: Long-term
outcomes, prognostic value, & accuracy. Otolaryngology-Head and Neck Surgery, 162(4):520-529,
2020, PMCID:PMC8012010.
Sun Y, Patel A, SantaLucia J, Roberts E, Zhao L, Kaye K, Rao K, Bachman MA. Measurement
of klebsiella intestinal colonization density to assess infection risk. mSphere. 6(3):e0050021,
2021, PMCID:PMC8265666.
Roberts E, Zhao L. A Bayesian mixture model for changepoint estimation using ordinal
predictors. Int J Biostat. 2021 Apr 6. doi: 10.1515/ijb-2020-0151, 2021, PMID:33823087.
Roberts EK, Elliott MR, Taylor JMG/ Incorporating baseline covariates to validate
surrogate endpoints with a constant biomarker under control arm. Stat Med, 40(29),
6605-6618, 2021.
Roberts EK, Elliott MR, Taylor JMG. Solutions for surrogacy validation with longitudinal
outcomes for a gene therapy. Biometrics. In Press.
Hu C, Tsodikov A. Semiparametric regression analysis for time-to-event marked endpoints
in cancer studies. Biostatistics,5(3) 513-525, 2014, PMCID:PMC4102917.
Hu C, Tsodikov A. Joint modeling approach for semicompeting risks data with missing
nonterminal event status. Lifetime Data Anal, 20(4)563-583, 2014, PMCID:PMC4101077.
Dess RT, Hartman HE, Aghdam N, Jackson WC, Soni PD, Abugharib AE, Suy S, Desai NB,
Zumsteg ZS, Mehra R, Morgan TM, Feng FY, Hamstra DA, Schipper MJ, Collins SP, Spratt
DE. Erectile function after stereotactic body radiotherapy for localized prostate
cancer. BJU Int. 121(1):61-68, 2018, PMID:28710895.
Hartman H, Wang Y, Schroeder HW Jr, Cui X. Absorbance summation: A novel approach
for analyzing high-throughput ELISA data in the absence of a standard. PLoS One, 13(6):e0198528,
2018, PMCID:PMC5993274.
Wahl DR, Kim MM, Aryal MP, Hartman H, Lawrence TS, Schipper MJ, Parmar HA, Cao Y.
Combining perfusion and high B-value fiffusion MRI to inform prognosis and predict
failure patterns in glioblastoma. Int J Radiat Oncol Biol Phys, 102(4):757-764, 2018,
PMID:29980414.
Jackson WC, Silva J, Hartman HE, Dess RT, Kishan AU, Beeler WH, Gharzai LA, Jaworski
EM, Mehra R, Hearn JWD, Morgan TM, Salami SS, Cooperberg MR, Mahal BA, Soni PD, Kaffenberger
S, Nguyen PL, Desai N, Feng FY, Zumsteg ZS, and Spratt DE. Stereotactic body radiation
therapy for localized prostate cancer: a systematic review and metaanalysis of over
6,000 patients treated on prospective studies. Internation Journal of Radiation Oncology
Biology Physics, 104:778–789, 2019, PMCID:PMC6770993.
*Dess RT, *Hartman HE, *Mahal BA, Soni PD, Jackson WC, Cooperberg MR, Amling CL, Aronson
WJ, Kane CJ, Terris MK, Zumsteg ZS, Butler S, Osborne JR, Morgan TM, Mehra R, Salami
SS, Kishan AU, Wang C, Schaeffer, EM, Roach III M, Pisansky TM, Shipley WU, Freedland
SJ, Sandler HM, Halabi S, Feng FY, Dignam JJ, Nguyen PL, Schipper MJ, and #Spratt
DE. Association of black race with prostate cancer-specific and other-cause mortality.
JAMA Oncology, 5(7):975-983, 2019, PMCID:PMC6547116.
Soni PD, Hartman HE, Dess RT, Abugharib A, Allen SG, Feng FY, Zeitman AL, Jagsi R,
Schipper MJ, and #Spratt DE. Comparison of population-based observational studies
with randomized trials in oncology. Journal of Clinical Oncology, 37(14):1209-1216,
2019, PMCID:PMC7186578.
Mendiratta-Lala M, Masch W, Shankar PR, Hartman HE, Davenport MS, Schipper MJ, Maurino
C, Cuneo KC, Lawrence TS, and Owen D. Magnetic resonance imaging evaluation of hepatocellular
carcinoma treated with stereotactic body radiation therapy: long term imaging follow-up.
International Journal of Radiation Oncology Biology Physics, 37(14):1209-1216, 2019,
PMCID:PMC6301102.
Hartman HE, Sun Y, Devasia T, Chase E, Jairath, NK, Dess RT, Jackson WC, Morris E,
Li P, Hochstedler KA, Abbott M, Kidwell K, Walter V, Wang M, Wang X, Zaorsky N, Schipper
MJ, and #Spratt DE. Integrated survival estimates from cancer treatment delay during
the Covid-19 pandemic., JAMA Oncology, 6(12):1881-1889, 2020, PMCID:PMC7596687.
Nuccitelli R, McDaniel A, Connolly R, Zelickson B, Hartman H. Nano-Pulse stimulation
induces changes in the intracellular organelles in rat liver tumors treated in Situ.
Lasers Surg Med, 52(9):882-889, 2020, PMC:PMC7586959.
Jackson WC, Hartman HE, Dess RT, Birer SR, Soni PD, Hearn JWD, Reichert ZR, Kishan
AU, Mahal BA, Zumsteg ZS, Efstathiou JA, Kaffenberger S, Morgan TM, Mehra R, Showalter
TN, Krauss DA, Nguyen PL, Schipper MJ, Feng FY, Sandler HM, Hoskin PJ, Roach M 3rd,
Spratt DE. Addition of androgen-deprivation therapy or brachytherapy boost to external
beam radiotherapy for localized prostate cancer: a network meta-analysis of randomized
trials. J Clin Oncol, 38(26):3024-3031, 2020, PMCID:PMC8265327.
Hartman HE, Jackson WC. Surrogate endpoints in localized prostate cancer. Cancer J,
26(1):48-52, 2020, PMID:31977385.
Ma TM, Romero T, Nickols NG, Rettig MB, Garraway IP, Roach M 3rd, Michalski JM, Pisansky
TM, Lee WR, Jones CU, Rosenthal SA, Wang C, Hartman H, Nguyen PL, Feng FY, Boutros
PC, Saigal C, Chamie K, Jackson WC, Morgan TM, Mehra R, Salami SS, Vince R, Schaeffer
EM, Mahal BA, Dess RT, Steinberg ML, Elashoff D, Sandler HM, Spratt DE, Kishan AU.
Comparison of response to definitive radiotherapy for localized prostate cancer in
black and white men: A Meta-analysis. JAMA Netw Open, 1;4(12)e2139769, 2021, PMCID:PMC8717118.
Spratt DE, Malone S, Roy S, Grimes S, Eapen L, Morgan SC, Malone J, Craig J, Dess
RT, Jackson WC, Hartman HE, Kishan AU, Mehra R, Kaffenberger S, Morgan TM, Reichert
ZR, Alumkal JJ, Michalski J, Lee WR, Pisansky TM, Feng FY, Shipley W, Sandler HM,
Schipper MJ, Roach M 3rd, Sun Y, Lawton CAF. Prostate Radiotherapy with Adjuvant Androgen
Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant
ADT: An Individual Patient Meta-Analysis. .J Clin Oncol, 39(2):136-144, 2021 PMCID:PMC8189640.
Hartman H, Tamura RN, Schipper MJ, Kidwell KM. Design and analysis considerations
for utilizing a mapping function in a small sample, sequential, multiple assignment,
randomized trials with continuous outcomes. Stat Med, 40(2):312-326, 2021 PMCID:PMC9109654.
Jackson WC, Hartman HE, Gharzai LA, Maurino C, Karnak DM, Mendiratta-Lala M, Parikh
ND, Mayo CS, Haken RKT, Schipper MJ, Cuneo KC, Lawrence TS. The Potential for Midtreatment
Albumin-Bilirubin (ALBI) Score to Individualize Liver Stereotactic Body Radiation
Therapy. Int J Radiat Oncol Biol Phys, 111(1):127-134, 2021, PMID:33878421.
Chase E and Boonstra P . Accounting for established predictors with the multi-step
elastic net. Stat Med, 38(23):4534-4544, 2019, PMCID:PMC6736688
Hartman H, Sun Y, Devasia T, Chase E, Jairath N, Dess R, Jackson W, Morris E, Li P,
Hochstedler K, Abbott M, Kidwell K, Walter V, Wang M, Wang X, Zaorsky N, Schipper
M, Spratt D. Integrated survival estimates for cancer treatment delay among adults
with cancer during the coronavirus disease 2019 (COVID-19) Pandemic. JAMA Oncology,
6(12):1881-1889, 2020, PMCID:PMC7596687
Boonstra P, Braun T, Chase E. A modular framework for seamless oncology trials. Clinical
Trials, 18(3):303-313, 2021, PMCID:PMC8382494
Ezell JM, Griswold D, Chase EC, Carver E. The blueprint of disaster: COVID-19, the
Flint water crisis, and unequal ecological impacts. Lancet Planet Health, 5(5):e309-e315,
2021, PMID:33964240.
Ezell JM, Chase EC. A population-based assessment of physical symptoms and mental
health outcomes among adults following the flint water crisis. J Urban Health, 98(5):642-653,
2021, PMCID:PMC8566686.
Chase E, Bryant K, Sun Y, Jackson WC, Spratt D, Dess RT, Schipper M. Development and
validation of a life expectancy calculator for U.S. prostate cancer patients. BJU
International, 130(4):496-506, 2022, PMCID:PMC9474626.
Fritsche L, Beesley L, VandeHaar P, Peng R, Salvatore M, Zawistowski M, Taliun S,
LeFaive J, Kaleba E, Klumpner T, Moser S, Blanc V, Mukherjee B. Exploring various
polygenic risk scores for skin cancer in the phenomes of the Michigan genomics initiative
and the UK Biobank with a visual catalog: PRSWeb. Plos Genetics, 15(6):e1008202, 2019,
PMCID:PMC6592565.
Fritsche LG, Patil S, Beesley LJ, VandeHaar P, Salvatore M, Ma Y, Peng RB, Taliun
D, Zhou X, Mukherjee B. Cancer PRSweb: An online repository with polygenic risk scores
for major cancer traits and their evaluation in two independent biobanks. Am J Hum
Genet, 107(5):815-836, 2020, PMCID:PMC7675001.
Tosoian JJ, Feldman A, Abbott MR, Mehra R, Tiemeny P, Wolf JS, Stone S, Wu S, Daignault-Newton
S, Taylor JMG, Wu C-L, Morgan TM. Biopsy cell cycle proliferation score predicts adverse
surgical pathology in localized renal cell carcinoma Eur Urol, 78(5):657-660, 2020,
PMID:32943262.
Hartman HE, Sun Y, Devasia TP, Chase EC, Jairath NK, Dess RT, Jackson WC, Morris
E, Li P, Hochstedler KA, Abbott MR, Kidwell KM, Walter V, Wang M, Wang X, Zaorsky
NG, Schipper MJ, Spratt DE. Integrated survival estimates for cancer treatment delay
among adults with cancer during the COVID-19 pandemic. JAMA Oncology, 6(12):1881-1889,
2020, PMCID:PMC7596687.
Meng X, Chang TS, Feng S, Lee M, Jaiswal S, Choi EY, Tran L. et al. Multi-modal imaging
for uptake of peptide ligand specific for CD44 by hepatocellular carcinoma. Photoacoustics,
26:100355, 2022, PMCID:PMC9035732.
Tran L, He K, Wang D, Jiang H. A Cross-validation statistical framework for asymmetric
data integration. Biometrics, 2022, doi: 10.1111/biom.13685, PMID:35524490.
Brown DL, Shafie-Khorassani F, Kim S, Chervin RD, Case E, Yadollahi A, Lisabeth LD.
Do apneas and hypopneas best reflect risk for poor outcomes after stroke? Sleep Medicine,
63:14-17, 2019, PMCID:PMC6939631.
Lank RJ, Lisabeth LD, Levine DA, Zahuranec DB, Kerber KA, Shafie-Khorassani F, Case
E, Zuniga BG, Cooper GM, Brown DL, Morgenstern LB. Ethnic differences in 90-day post-stroke
medication adherence. Stroke, 50(6): 1519-1524, 2019, PMCID:PMC6597008.
Shafie-Khorassani F, Piper ME, Jorenby DE, Baker TB, Benowitz NL, Hayes-Birchler T,
Meza R, Brouwer AF. The impact of demographics, dependence, and biomarkers on transitions
in tobacco product use in a cohort of smokers and dual users. Accepted in Nicotine
and Tobacco Research. 2022.
Schütz SG, Lisabeth LD, Shafie-Khorassani F, Case E, Sánchez BN, Chervin RD, Brown
DL. Clinical phenotypes of obstructive sleep apnea after ischemic stroke: a cluster
analysis. Sleep Medicine, 60:178-181, 2019, PMCID:PMC7424592.
Bailoor K, Shafie-Khorassani F, Lank RJ, Case E, Garcia NM, Lisabeth LD, Sánchez BN,
Morgenstern LB, Zahuranec DB. Time trends in race-ethnic differences in do-not-resuscitate
orders after stroke. Stroke, 50(7):1641-1647, 2019, PMCID:PMC6597008.
Brown DL, Shafie-Khorassani F, Kim S, Chervin RD, Case E, Morgenstern LB, Yadollahi
A, Tower S, Lisabeth LD. Sleep-disordered breathing is associated with recurrent ischemic
stroke. Stroke, 2019, 50(3):571-576, 2019, PMCID:PMC6389387.
Sozener CB, Lisabeth LD, Shafie-Khorassani F, Kim S, Zahuranec DB, Brown DL, Skolarus
LE, Burke JF, Kerber, KA, Meurer WJ, Garcia N, Case E, Morgenstern LB. Trends in stroke
recurrence in Mexican Americans and non-Hispanic whites. Stroke, 51(8):2428-2434,
2020, PMCID:PMC7387185.
Markovitz N, Morgenstern LB, Shafie-Khorassani F, Cornett BA , Kim S, Ortiz C, Lank
RJ, Case E, Zahuranec DB. Family perceptions of quality of end-of-life care in stroke.
Palliative Medicine Reports, 1(1):129-134, 2020, PMCID:PMC7446249.
Lank RJ, Shafie-Khorassani F, Zhang X, Ortiz C, Kim S, Sánchez BN, Case E, Creutzfeldt
CJ, Morgenstern LB, Zahuranec DB. Advance care planning and transitions to comfort
measures after stroke. Journal of Palliative Medicine, 24(8):1191-1196, 2021, PMCID:PMC8309394.
Ma V, Su C, Hu M, Taylor J, Daignault-Newton S, Kellezi O, Dahl M, Shah M, Erickson
S, Lora J, Hamasha R, Ali A, Yancey S, Kiros L, Balicki H, Winfield D, Green M, Alva
A. Characterization of outcomes in patients with advanced genitourinary malignancies
treated with immune checkpoint inhibitors. Urol Oncol, 39(7):437.e9, 2021, PMCID:PMC8286282.
Levy DT, Meza R, Yuan Z, Li Y, Cadham C, Sanchez-Romero LM, Travis N, Knoll M, Liber
AC, Mistry R, Hirschtick JL, Fleischer NL, Skolnick S, Brouwer AF, Douglas C, Jeon
J, Cook S, Warner KE. Public health impact of a US ban on menthol in cigarettes and
cigars: a simulation study. Tobacco Control, doi: 10.1136/tobaccocontrol-2021-056604,
2021, PMCID: PMC9210349.
Levy DT, Sanchez-Romero LM, Travis N, Yuan Z, Li Y, Skolnick S, Jeon J, Tam J, Meza
R. US Nicotine Product SimSmoke Simulation Model: The effect of vaping and tobacco
control policies on smoking prevalence and smoking attributable deaths. International
J Environmental Research and Public Health, 18(9):4876, 2021, PMCID:PMC8124578.
